# Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

> **NCT03645681** · NA · TERMINATED · sponsor: **W.L.Gore & Associates** · enrollment: 26 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Renal Dialysis

## Interventions

- **DEVICE:** InnAVasc arteriovenous graft surgical implant

## Key facts

- **NCT ID:** NCT03645681
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-02
- **Primary completion:** 2019-09-28
- **Final completion:** 2024-01-16
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Concerns around a high rate of thrombosis associated with kinking between the pod and the non-ringed graft.
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03645681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03645681, "Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03645681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*